Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor CeritinibAnke van Erp, Yvonne M.H. Versleijen‐Jonkers|Targeted Oncology|2017Cited by 39
Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivoAnke van Erp, Winette T.A. van der Graaf|Journal of Cancer Research and Clinical Oncology|2020Cited by 27